{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:49Z","timestamp":1786119589513,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1097\/aog.0b013e3181ec622b","type":"journal-article","created":{"date-parts":[[2010,8,25]],"date-time":"2010-08-25T03:23:22Z","timestamp":1282706602000},"page":"625-632","source":"Crossref","is-referenced-by-count":124,"title":["Levonorgestrel-Releasing Intrauterine System or Medroxyprogesterone for Heavy Menstrual Bleeding"],"prefix":"10.1097","volume":"116","author":[{"given":"Andrew M.","family":"Kaunitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Bissonnette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilza","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eeva","family":"Lukkari-Lax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Muysers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey T.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20210126","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/01.AOG.0000285997.38553.4b","article-title":"Hysterectomy rates in the United States, 2003.","volume":"110","author":"Wu","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R2-12-20210126","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ajog.2007.05.039","article-title":"Inpatient hysterectomy surveillance in the United States, 2000\u20132004.","volume":"198","author":"Whiteman","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R4-12-20210126","first-page":"683","article-title":"Work loss associated with increased menstrual loss in the United States.","volume":"100","author":"Cote","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R7-12-20210126","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jmig.2007.04.004","article-title":"Long-term complications of endometrial ablation: cause, diagnosis, treatment, and prevention.","volume":"14","author":"McCausland","year":"2007","journal-title":"J Minim Invasive Gynecol"},{"key":"R8-12-20210126","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/GRF.0b013e3181621f97","article-title":"Global endometrial ablation devices.","volume":"51","author":"Zarek","year":"2008","journal-title":"Clin Obstet Gynecol"},{"key":"R9-12-20210126","first-page":"57","article-title":"Continuous oral or intramuscular medroxyprogesterone acetate versus the levonorgestrel releasing intrauterine system in the treatment of perimenopausal menorrhagia: a randomized, prospective, controlled clinical trial in female smokers.","volume":"35","author":"Kucuk","year":"2008","journal-title":"Clin Exp Obstet Gynecol"},{"key":"R10-12-20210126","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/00365516409060511","article-title":"Determination of menstrual blood loss.","volume":"16","author":"Hallberg","year":"1964","journal-title":"Scand J Clin Lab Invest"},{"key":"R11-12-20210126","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1479-828X.1990.tb02028.x","article-title":"Treatment of ovulatory and anovulatory dysfunctional uterine bleeding with oral progestogens.","volume":"30","author":"Fraser","year":"1990","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R12-12-20210126","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1080\/01443619866336","article-title":"A double-blind randomised study comparing danazol and medroxyprogesterone acetate in the management of menorrhagia.","volume":"18","author":"Dunphy","year":"1998","journal-title":"J Obstet Gynaecol"},{"key":"R13-12-20210126","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0002-9378(11)90533-X","article-title":"A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia.","volume":"164","author":"Milsom","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"R14-12-20210126","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/j.1471-0528.2005.00642.x","article-title":"Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts.","volume":"112","author":"Reid","year":"2005","journal-title":"BJOG"},{"key":"R15-12-20210126","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1080\/01443610600913932","article-title":"Role of tranexamic acid in management of dysfunctional uterine bleeding in comparison with medroxyprogesterone acetate.","volume":"26","author":"Kriplani","year":"2006","journal-title":"J Obstet Gynaecol"},{"key":"R17-12-20210126","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S1701-2163(16)34151-2","article-title":"A Canadian, multicentre study comparing the efficacy of a levonorgestrel-releasing intrauterine system to an oral contraceptive in women with idiopathic menorrhagia.","volume":"31","author":"Endrikat","year":"2009","journal-title":"J Obstet Gynaecol Can"},{"key":"R18-12-20210126","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1471-0528.1998.tb10172.x","article-title":"Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia.","volume":"105","author":"Irvine","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"key":"R19-12-20210126","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/AOG.0b013e3181a1d3ce","article-title":"Levonorgestrel-releasing intrauterine system and endometrial ablation in heavy menstrual bleeding: a systematic review and meta-analysis.","volume":"113","author":"Kaunitz","year":"2009","journal-title":"Obstet Gynecol"},{"key":"R20-12-20210126","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jmig.2008.09.608","article-title":"The impact of alternative treatment for abnormal uterine bleeding on hysterectomy rates in a tertiary referral center.","volume":"16","author":"van Dongen","year":"2009","journal-title":"J Minim Invasive Gynecol"},{"key":"R21-12-20210126","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0140-6736(00)03615-1","article-title":"Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial.","volume":"357","author":"Hurskainen","year":"2001","journal-title":"Lancet"},{"key":"R22-12-20210126","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/jama.291.12.1456","article-title":"Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up.","volume":"291","author":"Hurskainen","year":"2004","journal-title":"JAMA"},{"key":"R23-12-20210126","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jmig.2005.12.006","article-title":"Pregnancy after endometrial ablation: English literature review and case report.","volume":"13","author":"Lo","year":"2006","journal-title":"J Minim Invasive Gynecol"},{"key":"R24-12-20210126","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0010-7824(02)00283-4","article-title":"Therapeutic use of levonorgestrel-releasing intrauterine system in women with menorrhagia: a pilot study(1).","volume":"65","author":"Monteiro","year":"2002","journal-title":"Contraception"},{"key":"R25-12-20210126","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0015-0282(02)04913-0","article-title":"Therapeutic effects of the levonorgestrel-releasing intrauterine system in the treatment of idiopathic menorrhagia.","volume":"79","author":"Xiao","year":"2003","journal-title":"Fertil Steril"},{"key":"R26-12-20210126","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.contraception.2006.03.024","article-title":"Cost-effectiveness of treatments for dysfunctional uterine bleeding in women who need contraception.","volume":"74","author":"Blumenthal","year":"2006","journal-title":"Contraception"},{"key":"R29-12-20210126","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0301-2115(98)00224-3","article-title":"Clinical associations with objective menstrual blood volume.","volume":"82","author":"Higham","year":"1999","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-201009000-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:35:49Z","timestamp":1786041349000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-201009000-00012"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e3181ec622b","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.5293959.793501004","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.5293959.5237059","asserted-by":"object"}]},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}